ReadCoor, Inc.
ReadCoor is commercializing a new generation sequencing platform that enables researchers to perform high throughput RNA-Seq while preserving sample morphology and simultaneously providing cellular location and spatial image data. This powerful tool is the first and only implementation of “In-situ Sequencing” and will revolutionize the next phase in understanding the transcriptome.
We Work For Health MA
We Work For Health is a grassroots initiative that shows how biopharmaceutical research and medical innovation work together to create a strong, vibrant economy and a healthier America. We unite biopharmaceutical companies with business and community partners to raise awareness about the vital role we all play in delivering life-saving and life-enhancing advancements in medicine, while educating elected leaders on the impact that public policies have on our ability to continue to innovate.
Neuroelectrics
Neuroelectrics is a digital brain health company with proprietary device and software technology to diagnose and treat brain disorders, and improve overall brain health. Current programs include development of neurophysiological biomarkers for early detection and diagnosis of Parkinson’s disease, and an FDA-approved clinical trial for a digital therapeutic device to treat drug resistant epilepsy. Our goal is to be the partner of choice for neuro-pharmaceutical and biotech companies, developing neurophysiological biomarkers for clinical drug development, diagnostics, and combination drug-device CNS therapies.
AICEP-Portugal Trade & Investment Agency
Aicep Portugal Global – Trade & Investment Agency is a government business entity, created in 2007, focused in encouraging the best foreign companies to invest in Portugal and contribute to the success of Portuguese companies abroad in their internationalization processes or export activities.